YAKUGAKU ZASSHI 1980-03-01

[The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione (suxibuzone), antiinflammatory drug. II. The biological fate of suxibuzone (SB) after daily oral administration (author's transl)].

K Taira, Y Yasuda, T Shindo, N Mitani, A Akazawa

Index: Yakugaku Zasshi 100(3) , 272-9, (1980)

Full Text: HTML

Abstract


Related Compounds

Related Articles:

[The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione(suxibuzone), antiinflammatory drug. I. Plasma levels and urinary excretion after oral administration of suxibuzone (author's transl)].

1979-12-01

[Yakugaku Zasshi 99(12) , 1186-200, (1979)]

Pro-drugs of non-steroidal anti-inflammatory agents.

1983-01-01

[Eur. J. Rheumatol. Inflamm. 6(2) , 141-2, (1983)]

Antemortem diagnosis of a distal axonopathy causing severe stringhalt in a horse.

2010-01-01

[J. Vet. Intern. Med. 24(1) , 220-3, (2010)]

Disposition of human drug preparations in the horse. I. Rectally administered indomethacin.

1991-06-01

[J. Vet. Pharmacol. Ther. 14(2) , 145-9, (1991)]

Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses.

2009-01-01

[Vet. Ther. 10(3) , 113-20, (2009)]

More Articles...